EP1904076A4 - COMPOSITIONS PENETRATING IN THE CORE OF THE CELL - Google Patents

COMPOSITIONS PENETRATING IN THE CORE OF THE CELL

Info

Publication number
EP1904076A4
EP1904076A4 EP05802798A EP05802798A EP1904076A4 EP 1904076 A4 EP1904076 A4 EP 1904076A4 EP 05802798 A EP05802798 A EP 05802798A EP 05802798 A EP05802798 A EP 05802798A EP 1904076 A4 EP1904076 A4 EP 1904076A4
Authority
EP
European Patent Office
Prior art keywords
penetrating
compositions
core
cell
compositions penetrating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05802798A
Other languages
German (de)
French (fr)
Other versions
EP1904076A1 (en
Inventor
Ewald Hannappel
Thomas Huff
Allan L Goldstein
David Crockford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Friedrich-Alexander-Universität Erlangen-Nürnberg
RegeneRx Biopharmaceuticals Inc
Original Assignee
Friedrich-Alexander-Universität Erlangen-Nürnberg
RegeneRx Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Friedrich-Alexander-Universität Erlangen-Nürnberg, RegeneRx Biopharmaceuticals Inc filed Critical Friedrich-Alexander-Universität Erlangen-Nürnberg
Publication of EP1904076A1 publication Critical patent/EP1904076A1/en
Publication of EP1904076A4 publication Critical patent/EP1904076A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
EP05802798A 2005-05-27 2005-10-03 COMPOSITIONS PENETRATING IN THE CORE OF THE CELL Withdrawn EP1904076A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68499305P 2005-05-27 2005-05-27
PCT/US2005/035716 WO2006130171A1 (en) 2005-05-27 2005-10-03 Cell nucleus-entering compositions

Publications (2)

Publication Number Publication Date
EP1904076A1 EP1904076A1 (en) 2008-04-02
EP1904076A4 true EP1904076A4 (en) 2009-12-09

Family

ID=37481967

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05802798A Withdrawn EP1904076A4 (en) 2005-05-27 2005-10-03 COMPOSITIONS PENETRATING IN THE CORE OF THE CELL

Country Status (9)

Country Link
EP (1) EP1904076A4 (en)
JP (1) JP2008542265A (en)
KR (1) KR20080016675A (en)
CN (1) CN101184498A (en)
AU (1) AU2005332297A1 (en)
CA (1) CA2607701A1 (en)
IL (1) IL187217A0 (en)
MX (1) MX2007014803A (en)
WO (1) WO2006130171A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110172155A1 (en) * 2008-03-17 2011-07-14 Regenerx Biopharmaceuticals, Inc. Beta thymosin fragments
CN110790821B (en) * 2019-11-19 2022-09-02 南阳师范学院 Cell nucleus penetrating peptide and application thereof
CN115266995B (en) * 2022-08-02 2023-10-13 兆科(广州)眼科药物有限公司 Analysis method of related substances in pilatory peptide preparation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001090345A2 (en) * 2000-05-22 2001-11-29 Children's Hospital Of Philadelphia Methods and compositions for enhancing the delivery of a nucleic acid to a cell
WO2005007118A2 (en) * 2003-07-18 2005-01-27 Regenerx Biopharmaceuticals, Inc. Treatment or prevention of damage due to radiation exposure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004229336B2 (en) * 2003-03-31 2008-12-04 Regenerx Biopharmaceuticals, Inc. Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives
WO2004099768A1 (en) * 2003-05-05 2004-11-18 Regenerx Biopharmaceuticals, Inc. Method for detecting development of a physiological disorder in a subject

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001090345A2 (en) * 2000-05-22 2001-11-29 Children's Hospital Of Philadelphia Methods and compositions for enhancing the delivery of a nucleic acid to a cell
WO2005007118A2 (en) * 2003-07-18 2005-01-27 Regenerx Biopharmaceuticals, Inc. Treatment or prevention of damage due to radiation exposure

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HUFF THOMAS ET AL: "Nuclear localisation of the G-actin sequestering peptide thymosin beta4.", JOURNAL OF CELL SCIENCE 15 OCT 2004, vol. 117, no. Pt 22, 15 October 2004 (2004-10-15), pages 5333 - 5341, XP002551253, ISSN: 0021-9533 *
See also references of WO2006130171A1 *

Also Published As

Publication number Publication date
WO2006130171A1 (en) 2006-12-07
EP1904076A1 (en) 2008-04-02
AU2005332297A1 (en) 2006-12-07
MX2007014803A (en) 2008-04-21
CA2607701A1 (en) 2006-12-07
JP2008542265A (en) 2008-11-27
CN101184498A (en) 2008-05-21
IL187217A0 (en) 2008-02-09
KR20080016675A (en) 2008-02-21

Similar Documents

Publication Publication Date Title
BRPI0810472A2 (en) METHODS RELATED TO CELL SURFACE GLYCOSILATION
NO2018027I2 (en) [18F] FACBC or fluciclobin
PT1943264E (en) ANALOGS OF OLIGONUCLEOSIDES INCORPORATING THEM IN 5-AZACITOSIN
BRPI0810813A2 (en) Double acting antihypertensive agents
EP1838220A4 (en) bioptome
DK1951885T3 (en) SITU FRUCTOOLIGOSACCHARIDE PREPARATION AND SUGAROSE REDUCTION
BRPI0716327A2 (en) Phenylpropionamide Compound and Use
EP1788047A4 (en) HYDROFUGE / OLEOFUGE COMPOSITION
EP2030606A4 (en) CAPILLARY DYE COMPOSITION IN MONOPIENE CASE
NO20055686D0 (en) Composition
EP1909097A4 (en) BIOSENSOR AND BIOSENSOR CELL
EP1897558A4 (en) SOLID PREPARATION
EP1891264A4 (en) FLOTATION CELL
EP1942232A4 (en) CONSTRUCTION STRUCTURE
EP1865042A4 (en) ANTI-FREEZE COMPOSITION
EP1884275A4 (en) ALVEOLAR STRUCTURE BODY
EP1849798A4 (en) PEPTIDE CAPABLE OF PENETRATING IN CELLS
EP1870942A4 (en) SOLAR CELL
EP2155914A4 (en) IMPROVEMENTS IN THE PRODUCTION OF FERROALLIAGES
DK1967534T3 (en) Adhesive composition
DE602005017191D1 (en) ODOR-REDUCED WASHPIECE COMPOSITION
DE602006016400D1 (en) IN ORDER TO
EP1920026A4 (en) IMPROVED MICROGRAPHIC SOLUTION
DE602005007582D1 (en) IN BIOLOGICAL SAMPLES
DE602006011271D1 (en) ANTHELMINTHIC COMPOSITION

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071218

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1114564

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20091106

17Q First examination report despatched

Effective date: 20100212

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110503

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1114564

Country of ref document: HK